Mineralys Therapeutics, Inc. (MLYS) Ownership

$13.05

north_east
$0.3 (2.35%)
Day's range
$12.73
Day's range
$13.08

Mineralys Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 02/14/2025 8.64 M $106.41 M   0.00% 17.30%
SAMSARA BIOCAPITAL, LLC 02/14/2025 5.07 M $62.47 M   0.00% 10.16%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 4.85 M $59.72 M   0.00% 9.71%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 2.47 M $30.41 M   0.00% 4.94%
BLACKROCK FUNDING, INC. /DE 02/07/2025 2.14 M $26.33 M   -0.26% 4.28%
SR ONE CAPITAL MANAGEMENT, LP 02/13/2025 2.02 M $24.83 M   0.00% 4.04%
FRANKLIN RESOURCES INC 02/12/2025 1.75 M $21.49 M   0.00% 3.49%
ORBIMED ADVISORS LLC 02/14/2025 1.61 M $19.84 M   -19.54% 3.23%
LAURION CAPITAL MANAGEMENT LP 02/14/2025 1.41 M $17.39 M   0.00% 2.83%
ADAMS STREET PARTNERS LLC 02/14/2025 1.13 M $13.91 M   -26.28% 2.26%
JENNISON ASSOCIATES LLC 01/24/2025 1.08 M $13.32 M   55.40% 2.17%
CALIGAN PARTNERS LP 02/14/2025 1.01 M $12.45 M   3.06% 2.02%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 875,000 $10.77 M   145.79% 1.75%
AMERICAN CENTURY COMPANIES INC 02/11/2025 848,630 $10.45 M   -8.91% 1.70%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 841,541 $10.36 M   15.37% 1.68%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 650,023 $8.00 M   7.27% 1.30%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 632,506 $7.79 M   0.00% 1.27%
STEMPOINT CAPITAL LP 02/14/2025 400,101 $4.93 M   100.00% 0.80%
SECTORAL ASSET MANAGEMENT INC 02/14/2025 380,883 $4.69 M   15.59% 0.76%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 350,000 $4.31 M   0.00% 0.70%
IKARIAN CAPITAL, LLC 02/14/2025 332,390 $4.09 M   84.66% 0.67%
CANDRIAM S.C.A. 02/07/2025 305,272 $3.76 M   100.00% 0.61%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 190,672 $2.35 M   -30.02% 0.38%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 146,500 $1.80 M   0.00% 0.29%
PALE FIRE CAPITAL SE 02/13/2025 136,897 $1.69 M   0.00% 0.27%
POLAR ASSET MANAGEMENT PARTNERS INC. 02/25/2025 99,100 $1.22 M   144.69% 0.20%
NEOS INVESTMENT MANAGEMENT LLC 02/12/2025 89,529 $1.10 M   -27.51% 0.18%
02/14/2025 89,529 $1.10 M   100.00% 0.18%
LION POINT CAPITAL, LP 02/14/2025 79,000 $972,490   0.00% 0.16%
ALPS ADVISORS INC 02/13/2025 40,248 $495,453   5.19% 0.08%
UBS OCONNOR LLC 02/14/2025 28,068 $345,517   -9.66% 0.06%
PROFICIO CAPITAL PARTNERS LLC 02/05/2025 23,192 $23,192   100.00% 0.05%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 17,786 $218,946   100.00% 0.04%
LETKO, BROSSEAU & ASSOCIATES INC 02/14/2025 16,500 $203,115   44.74% 0.03%
BELLEVUE GROUP AG 02/14/2025 16,499 $203,103   0.00% 0.03%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 16,383 $201,675   4.36% 0.03%
QUEST PARTNERS LLC 02/07/2025 15,222 $187,383   2,637.77% 0.03%
MARTINGALE ASSET MANAGEMENT L P 02/13/2025 14,965 $184,220   0.00% 0.03%
COREBRIDGE FINANCIAL, INC. 02/11/2025 14,197 $174,765   -7.01% 0.03%
ENTRYPOINT CAPITAL, LLC 02/11/2025 12,487 $153,715   100.00% 0.03%
CREATIVEONE WEALTH, LLC 02/13/2025 10,750 $132,333   0.00% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 10,553 $129,907   10.34% 0.02%
02/11/2025 7,136 $87,844   100.00% 0.01%
VIRTUS ETF ADVISERS LLC 02/14/2025 5,842 $71,915   -19.61% 0.01%
SMARTLEAF ASSET MANAGEMENT LLC 02/05/2025 1,905 $23,850   23.94% 0.00%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 01/27/2025 1,658 $21,256   -7.84% 0.00%
GEOWEALTH MANAGEMENT, LLC 02/13/2025 1,439 $17,714   0.00% 0.00%
MEEDER ASSET MANAGEMENT INC 02/12/2025 1,338 $16,471   100.00% 0.00%
02/19/2025 1,045 $12,864   100.00% 0.00%
STERLING CAPITAL MANAGEMENT LLC 02/13/2025 723 $8,900   838.96% 0.00%

Mineralys Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 61 institutional investors and hedge funds held shares of Mineralys Therapeutics, Inc.. The most heavily invested institutionals were:

Catalys Pacific, LLC: 8.64 M

Samsara BioCapital, LLC: 5.07 M

RA CAPITAL MANAGEMENT, L.P.: 4.85 M

TCG Crossover Management, LLC: 2.47 M

BlackRock Funding, Inc. /DE: 2.14 M

SR ONE CAPITAL MANAGEMENT, LP: 2.02 M

93.04% of Mineralys Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 40.37 M shares in the last 24 months. This purchase volume represents approximately $526.79 M in transactions.